In addition, the complete control was with high significant differences between first, second, third, and fourth visits for groups A and B ( P < 0.0001) and borderline significant for group C ( P = 0.04).
Excerpts
Treatment with IMODTM showed a decreasing trend in IL-6 levels compared to the control group (p = 0.04).
showed a trendp = 0.04
The soluble human GSTO1 and GSTZ1 showed a trend toward an increase in the rate of GSH conjugation ( p = 0.04).
The minimally-adjusted effects of long-term limiting illness and difficulty walking were likewise attenuated and became marginally significant ( p = 0.04) after adjusting for SEP.
Treatment with Synbiotic 2000TM lead to a highly significant decrease in number of chest infections (4/26 patients - 15%), compared to peptide diet (11/26 patients - 42%, p < 0.04), glutamine (11/32 patients - 34%, p < 0.03) and only fibres (12/29 patients- 41%, p < 0.002) [ 58 ].
Clearly significant differences were observed for d N ( P = 3.50 × 10 –4 ), but only marginally significant differences were observed for d S ( P = 0.040; Table 1 ), indicating that the evolutionary patterns of nonsynonymous sites are the main responsible for the trend observed in ω .
A borderline significant association between STIM1 polymorphism rs1561876 and BASFI ( P -value = 0.04) or BAS-G ( P -value = 0.06) was found.
The clinical differences between both ASST positive and ASST negative patients did not show any statistical significance, except for angioedema was moderately significant ( P = 0.040) [ Table 3 ].
However, there was a slight increase in the left condyle’s angulation within the lag screw group, showing marginal significance (preoperative measure: 24.83 ± 6.37 vs. postoperative measure: 32.5 ± 4.93; P = 0.04).
Association between the C allele of rs4806718 with the affected status and the T allele with the asymptomatic status was moderately significant ( p = 0.04, by Fisher exact test).
Dabigatran 150 mg was found to have an increased rate of myocardial infarction (0.74%) when compared with warfarin (0.53%/year), although this effect did not reach statistical significance (RR 1.38, 95% CI 1–1.91, p=0.04).
As shown in Table 3 , there was evidence for a marginally significant effect of both GNB3 variants (C825T and G-350A) on DBP levels ( P = 0.04). 3.2.
However, from Week 6 to Week 12 the intervention group showed a large decrease, while the scores in the control group remained relatively stable, leading to a marginally significant (p = 0.04) larger total decrease in perceived stress from Week 0 to Week 12 in the intervention group.
In a meta-analysis of the two cohorts, the ACE polymorphism remained nominally significant ( P = 0.04).
At rs1477798 in 15q22.31 which showed evidence of linkage in clinic-based, larger families, a nominally significant case-control association was observed (OR 1.16, p = 0.04) which was modestly strengthened for cases with CRC family history (OR 1.24, p = 0.03); however, no significant difference in risk by family history was observed and associations were far from genome-wide significant.
Pooling autosomal mutations to compare against X mutations revealed a marginally significant difference in the autosomal versus X rate in PB306 ( P = 0.04, X 2 test) but not in the other three MA lines sets (0.30 < P < 0.86, X 2 tests).
The neurodevelopment score showed a negative trend with BDCIPP ( β = −1.42; 95% CI = −2.70; −0.06; p -value = 0.04) and no clear association with DPHP ( β = −1.09; 95% CI = −2.87; 0.68; p -value = 0.23).
Moreover, the marginally significant difference in PVD at baseline ( P = 0.04) represents a limitation of the present study.
Treatment with Synbiotic 2000TM led to a highly significant reduction in number of chest infections (4/26 patients—15%) compared to peptide diet (11/26 patients—42%, p < 0.04), glutamine treatment (11/32 patients—34%, p < 0.03) and only fiber treatment (12/29 patients—41%, p < 0.002) [ 61 ].
Similar results were observed with OCR, which was associated with a highly significant reduction in the risk of relapse at 1 year compared to FTY, with a hazard ratio of 3.4 ( P = 0.04). 114 Finally, there are few data to support the use of CLA in this situation.
There was also a significant trend towards increased carriage with number of inhabitants (i.e. 4 or more occupants per room) in a household (χ 2 = 4.3, p = 0.04).
Relationships between cooperativity and specialization versus network node and edge counts were either statistically significant or marginally significant (p = 0.04 and 0.06, 0.07 and 0.11, respectively) ( Fig. 4C, 4D ).
Secondly they showed a marginally significant difference ( p = 0.04) in the rate of lymph node involvement, with the highest being among Her2-overexpressing subtype (56%), followed by luminal B (47%), basal-like (41%), and luminal A (34%).
After adjusting for baseline characteristics, the association between the MMP9 R279Q variant and stroke was modestly significant, with participants carrying the minor G allele having decreased risk of stroke (HR = 1.00 for AA, 0.87 for GA, 0.91 for GG; P = 0.04, additive genetic model).
Shapiro-Wilk’s test for the total sample returned significant results only for fluency and elaboration, with marginal significance for flexibility ( p = .04).